ECDB-Endometrial cancer gene database

REFERENCES

Gene Name	Gene ID	Pubmed ID	Classification	Mechanism	Marker	Type	Normal Cases	Disease Cases	Age	Mean Age	Place	FIGO	Grade	Remark	Title	Journal	Volume	Year
TFF3	7033	15930340	-	Differentially expressed		-	-	119 (66 endometrioid; 24 papillary serous; 29 mixed mullerian tumors)	-	-	Duke University Medical Centre; North Carolina	-	-	[1] The microarray study shows that this gene is differently expressed in endometrioid carcinoma profile; reflecting expression value 5.819 and 19.348 on both the endometrioid versus papillary serous carcionma and endometrioid versus mixed mullerian tumor respectively. [2] This genes with a >2-fold endometrioid/papillary serous carcinoma expression ratio. [3] This shows a lower expression in mixed mullerian tumorspecimens when compared with endometrioid carcinomas	Microarray analysis of endometrial carcinomas and mixed mullerian tumors reveals distinct gene expression profiles associated with different histologic types of uterine cancer	Clinical Cancer Research	11(11):4056-66	2005
TFF3	7033	17043662	-	Up regulation/ Over expression/High expression	-	-	29	55	36 to 82 (disease); 38 to 85 (control	55.5 (disease); 52.8 (control)	"Department of Obstetrics and Gynaecology	The Chinese University of HingKong	Prince of Wales Hospital."	-	-	[1] This investigation suggests that this gene is differently regulated by 9.67 fold change in the pathogenesis of endometrial carcinoma.	Identification of molecular markers and signaling pathway in endometrial cancer in Hong Kong Chinese women by genome-wide gene expression profiling	0